Skip to main content
editorial
. 2021 Feb 15;10(2):85–93. doi: 10.1159/000514312

Table 2.

Comparison of kinase inhibitory effect on targeted molecule between lenvatinib and sorafenib

IC50, nmol/L
lenvatinib sorafenib
VEGFR-1 4.7 21
VEGFR-2 3 21
VEGFR-3 2.3 16
FGFR1 61 340
FGFR2 27 150
FGFR3 52 340
FGFR4 43 3,400
PDGFRα 29 1.6
PDGFRβ 160 27
RAF1 1,610 46.4
BRAF 8,660 314

VEGF, vascular endothelial growth factor. Bold character represents an inhibitory effect on each molecule. Modified from ref. [24].